Patrick Trucchio
Stock Analyst at HC Wainwright & Co.
(1.93)
# 3,032
Out of 4,876 analysts
380
Total ratings
31.93%
Success rate
-7.69%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Patrick Trucchio
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ANRO Alto Neuroscience | Reiterates: Buy | $10 | $2.30 | +334.78% | 2 | Jun 26, 2025 | |
| IVVD Invivyd | Reiterates: Buy | $5 | $0.80 | +525.86% | 19 | Jun 26, 2025 | |
| SGMO Sangamo Therapeutics | Reiterates: Buy | $10 | $0.56 | +1,694.37% | 26 | Jun 24, 2025 | |
| SLN Silence Therapeutics | Reiterates: Buy | $75 | $5.54 | +1,253.79% | 24 | Jun 13, 2025 | |
| IMCR Immunocore Holdings | Reiterates: Buy | $100 | $32.02 | +212.30% | 21 | Jun 2, 2025 | |
| QURE uniQure | Reiterates: Buy | $70 | $14.23 | +391.92% | 15 | May 29, 2025 | |
| ONCY Oncolytics Biotech | Reiterates: Buy | $5 | $0.72 | +594.44% | 18 | May 21, 2025 | |
| DTIL Precision BioSciences | Reiterates: Buy | $60 | $4.14 | +1,349.28% | 18 | May 21, 2025 | |
| ATAI Atai Life Sciences | Reiterates: Buy | $10 | $2.25 | +344.44% | 19 | May 20, 2025 | |
| ARWR Arrowhead Pharmaceuticals | Reiterates: Buy | $80 | $16.07 | +397.82% | 23 | May 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $45 | $2.66 | +1,591.73% | 15 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $12.40 | +222.58% | 15 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $2.97 | +910.10% | 10 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $70 | $31.86 | +119.71% | 6 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $80 | $17.14 | +366.74% | 8 | Apr 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $12 | $3.61 | +232.41% | 17 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $500 | $318.25 | +57.11% | 26 | Apr 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $10 | $1.94 | +415.46% | 19 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $1.30 | +669.23% | 16 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $55 | $6.74 | +716.02% | 18 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $110 | $5.31 | +1,971.56% | 23 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $85 | $24.78 | +243.02% | 2 | Feb 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $190 → $150 | $8.58 | +1,648.25% | 17 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $170 → $68 | $12.35 | +450.61% | 2 | Sep 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $260 → $340 | $305.52 | +11.29% | 1 | Aug 18, 2021 |
Alto Neuroscience
Jun 26, 2025
Reiterates: Buy
Price Target: $10
Current: $2.30
Upside: +334.78%
Invivyd
Jun 26, 2025
Reiterates: Buy
Price Target: $5
Current: $0.80
Upside: +525.86%
Sangamo Therapeutics
Jun 24, 2025
Reiterates: Buy
Price Target: $10
Current: $0.56
Upside: +1,694.37%
Silence Therapeutics
Jun 13, 2025
Reiterates: Buy
Price Target: $75
Current: $5.54
Upside: +1,253.79%
Immunocore Holdings
Jun 2, 2025
Reiterates: Buy
Price Target: $100
Current: $32.02
Upside: +212.30%
uniQure
May 29, 2025
Reiterates: Buy
Price Target: $70
Current: $14.23
Upside: +391.92%
Oncolytics Biotech
May 21, 2025
Reiterates: Buy
Price Target: $5
Current: $0.72
Upside: +594.44%
Precision BioSciences
May 21, 2025
Reiterates: Buy
Price Target: $60
Current: $4.14
Upside: +1,349.28%
Atai Life Sciences
May 20, 2025
Reiterates: Buy
Price Target: $10
Current: $2.25
Upside: +344.44%
Arrowhead Pharmaceuticals
May 20, 2025
Reiterates: Buy
Price Target: $80
Current: $16.07
Upside: +397.82%
May 12, 2025
Reiterates: Buy
Price Target: $45
Current: $2.66
Upside: +1,591.73%
May 9, 2025
Reiterates: Buy
Price Target: $40
Current: $12.40
Upside: +222.58%
Apr 8, 2025
Reiterates: Buy
Price Target: $30
Current: $2.97
Upside: +910.10%
Apr 8, 2025
Reiterates: Buy
Price Target: $70
Current: $31.86
Upside: +119.71%
Apr 7, 2025
Reiterates: Buy
Price Target: $80
Current: $17.14
Upside: +366.74%
Apr 3, 2025
Reiterates: Buy
Price Target: $12
Current: $3.61
Upside: +232.41%
Apr 2, 2025
Reiterates: Buy
Price Target: $500
Current: $318.25
Upside: +57.11%
Apr 1, 2025
Maintains: Buy
Price Target: $25 → $10
Current: $1.94
Upside: +415.46%
Mar 18, 2025
Reiterates: Buy
Price Target: $10
Current: $1.30
Upside: +669.23%
Mar 7, 2025
Reiterates: Buy
Price Target: $55
Current: $6.74
Upside: +716.02%
Feb 28, 2025
Reiterates: Buy
Price Target: $110
Current: $5.31
Upside: +1,971.56%
Feb 19, 2025
Reiterates: Buy
Price Target: $85
Current: $24.78
Upside: +243.02%
Feb 13, 2025
Maintains: Buy
Price Target: $190 → $150
Current: $8.58
Upside: +1,648.25%
Sep 23, 2022
Maintains: Buy
Price Target: $170 → $68
Current: $12.35
Upside: +450.61%
Aug 18, 2021
Maintains: Outperform
Price Target: $260 → $340
Current: $305.52
Upside: +11.29%